Importantly, higher CD97 expression levels are usually detected in the disseminated/scattered cells at the tumor invasion fronts and patients with more CD97-positive scattered tumor cells tend to have a poorer prognosis and enhanced lymph vessel invasion20. This evidence concerns the gene ADGRE5 and neoplasm.